Una candidatura completa in un minuto
Curriculum e lettera di presentazione personalizzati, pronti da inviare.
GSK is seeking a Director of Technology Risk & Compliance Business Partners for R&D, based in the UK with hybrid working, focused on Cambridge and Ware sites. You will translate cyber risk strategy into delivery plans, lead a risk-aware culture and oversee GxP regulatory technology in a rapidly evolving landscape.
You will own the relationship with R&D leadership, guide risk posture, manage audits, and collaborate across the Cyber Security Office to drive effective controls and timely CAPAs.
GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems. Our diverse portfolio consists of vaccines, specialty medicines, and general medicines. Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges.
The Director Technology Risk & Compliance Business Partners – R&D is a leadership role accountable being the primary point of contact for Technology Risk and Compliance across the R&D business unit and with particular focus on the Cambridge, UK and Ware, UK sites.
The Technology Risk and Compliance Business Partners are the face of the Cyber Security Office to GSK's business and technology areas. Each partner owns the cyber risk and compliance relationship for an assigned area, translating central strategy into what that area actually needs to do, and bringing its risk back into the Cyber Security Office.
We are looking for professionals with the following required skills to achieve our goals:
This role is based in the United Kingdom and offers a hybrid working model, with 2/3 days a week onsite at our central London HQ.
6th November 2026
Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.
This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.
We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are. Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us at UKRecruitment.Adjustments@gsk.com where you can also request a call. Please note that should your enquiry not relate to adjustments, we will not be able to support you through these channels. However, we have created a Recruitment FAQ guide. Click the link where you will find answers to multiple questions we receive.
We are a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years.